$ Value
$0
Shares
2,117
Price
$0
Filed
Sep 12
Insider
Name
Pelish Henry E.
Title
Chief Scientific Officer
CIK
0002029477
Roles
Transaction Details
Transaction Date
2025-09-10
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
14,850
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2024. | The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. | The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. | The shares underlying this option have vested or shall vest over the four years following March 1, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Filing Info
Pelish Henry E.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-09 | NUVL | M | $86K |
| 2026-04-09 | NUVL | ▼ | $229K |
| 2026-04-09 | NUVL | ▼ | $94K |
| 2026-04-09 | NUVL | M | $0 |
| 2025-10-15 | NUVL | M | $69K |
| 2025-10-15 | NUVL | M | $209K |
| 2025-10-15 | NUVL | M | $220K |
| 2025-10-15 | NUVL | ▼ | $1.3M |
| 2025-10-15 | NUVL | M | $0 |
| 2025-10-15 | NUVL | M | $0 |
Other Insiders at NUVL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Balcom Alexandra
Chief Financial Officer
|
— | $3.7M | 2026-04-01 |
|
Noci Darlene
Chief Development Officer
|
— | $538K | 2026-03-30 |
|
Porter James Richard
President and CEO
|
— | $3.1M | 2026-04-06 |
|
Miller Deborah Ann
Chief Legal Officer
|
— | $543K | 2026-03-26 |
|
Pelish Henry E.
Chief Scientific Officer
|
— | $323K | 2026-04-09 |
|
Lane Benjamin
See Remarks
|
— | — | 2026-04-01 |